INFLAMAX Trademark

Trademark Overview

On Wednesday, July 10, 2024, a trademark application was filed for INFLAMAX with the United States Patent and Trademark Office. The USPTO has given the INFLAMAX trademark a serial number of 98642385. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, February 19, 2025. This trademark is owned by Xenex Laboratories Inc.. The INFLAMAX trademark is filed in the Pharmaceutical Products category with the following description:

Topical cream for pain and inflammation relief
inflamax

General Information

Serial Number98642385
Word MarkINFLAMAX
Filing DateWednesday, July 10, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, February 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTopical cream for pain and inflammation relief

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXenex Laboratories Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoquitlam, BC V3K6C2
CA

Trademark Events

Event DateEvent Description
Wednesday, July 10, 2024NEW APPLICATION ENTERED
Wednesday, July 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 30, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 30, 2024SUSPENSION LETTER WRITTEN
Monday, December 30, 2024ASSIGNED TO EXAMINER
Monday, December 30, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, February 19, 2025LETTER OF SUSPENSION E-MAILED
Wednesday, February 19, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, February 19, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 19, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, February 19, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 19, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 19, 2025SUSPENSION LETTER WRITTEN

Related Keywords

inflamax relief inflammation pain cream topical